BMJ · 1996 · 59 citations · 4 references
PharmacyCommunity PharmacyPharmacy PracticeMedication Safety PolicyPharmaceutical CarePrescription DispensingAccess To MedicinesAdverse Drug Event ReportingAdverse Drug Reaction MonitoringAdverse Drug Reaction ReportingMedication UseSpontaneous Reporting SystemsOver-the-counter Drug UseOver-the-counter Medication AccessOver-the-counter Medication UseOver-the-counter MedicationsOver-the-counter Medicine Use
Cost and convenience influence patients' choice between OTC and prescription medicines, but prescription charge exemptions encourage continued NHS prescription use, creating a complex relationship between OTC availability and prescribing that burdens community pharmacists and calls for closer collaboration with general practitioners. The study aims to develop referral and recording systems for prescribed and OTC medicines and establish a direct route for pharmacists to report adverse drug reactions. The authors propose implementing systems for referral and recording of both prescribed and OTC medicines and creating a direct reporting route for pharmacists.
Cost and convenience seem to be major factors in determining whether, given the choice, patients purchase a medicine over the counter or obtain it on prescription. With current arrangements, exemption from prescription charges provides an incentive to continue to obtain products on NHS prescription even when they are available over the counter. There is therefore no simple relation between the availability of over the counter medicines and the level of prescribing of deregulated products. The appropriate use of over the counter medicines--particularly those that have only recently been deregulated--places a burden of care on community pharmacists and calls for closer working relationships with general practitioners. In particular, systems for referral and for recording details of both prescribed and over the counter medicines need to be developed, and a direct route needs to be established for community pharmacists to report adverse drug reactions to over the counter products.
4
Costs and benefits in switching drugs from Rx to OTC
Peter Temin · Journal of Health Economics · 1983 · 40 citations